{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:22:49Z","timestamp":1794208969376,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R37AG026160"],"award-info":[{"award-number":["R37AG026160"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR007612"],"award-info":[{"award-number":["T32AR007612"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.slasd.2026.100342","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:36:44Z","timestamp":1791387404000},"page":"100342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High-throughput discovery of actin-binding compounds for cardiac disorders"],"prefix":"10.1016","volume":"44","author":[{"given":"Scout","family":"Allendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8537-6776","authenticated-orcid":false,"given":"Andrew R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-2286","authenticated-orcid":false,"given":"Robyn T.","family":"Rebbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-2040","authenticated-orcid":false,"given":"David D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-7969","authenticated-orcid":false,"given":"Piyali","family":"Guhathakurta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2026.100342_bib0001","first-page":"22","article-title":"Cardiomyocyte dysfunction in inherited cardiomyopathies","author":"Hassoun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.slasd.2026.100342_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hfc.2017.12.007","article-title":"Epidemiology and clinical aspects of genetic cardiomyopathies","volume":"14","author":"Masarone","year":"2018","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.slasd.2026.100342_bib0003","article-title":"Hypertrophic cardiomyopathy","volume":"27","author":"Antunes","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.slasd.2026.100342_bib0004","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.slasd.2026.100342_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/ars.2017.7236","article-title":"Hypertrophic cardiomyopathy: a vicious cycle triggered by sarcomere mutations and secondary disease hits","volume":"31","author":"Wijnker","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.slasd.2026.100342_bib0006","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.slasd.2026.100342_bib0007","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.slasd.2026.100342_bib0008","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11886-022-01727-z","article-title":"Emerging genotype-phenotype associations in dilated cardiomyopathy","volume":"24","author":"Njoroge","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.slasd.2026.100342_bib0009","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41467-019-10555-9","article-title":"beta-cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity","volume":"10","author":"Adhikari","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2026.100342_bib0010","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.1074\/jbc.RA118.001938","article-title":"Dilated cardiomyopathy myosin mutants have reduced force-generating capacity","volume":"293","author":"Ujfalusi","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0011","first-page":"19","article-title":"Actin-myosin interaction: structure, function and drug discovery","author":"Guhathakurta","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.slasd.2026.100342_bib0012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fphys.2014.00090","article-title":"To understand muscle you must take it apart","volume":"5","author":"Batters","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.slasd.2026.100342_bib0013","first-page":"10","article-title":"Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics","author":"Schmid","year":"2021","journal-title":"Biol Open"},{"key":"10.1016\/j.slasd.2026.100342_bib0014","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.slasd.2026.100342_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.slasd.2026.100342_bib0016","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehaa1061","article-title":"The year in cardiovascular medicine 2020: heart failure and cardiomyopathies","volume":"42","author":"Bueno","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.slasd.2026.100342_bib0017","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40265-022-01728-w","article-title":"Pharmacological management of hypertrophic cardiomyopathy: from bench to bedside","volume":"82","author":"Palandri","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.slasd.2026.100342_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.slasd.2026.100342_bib0019","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.slasd.2026.100342_bib0020","first-page":"665","article-title":"Aficamten for obstructive hypertrophic cardiomyopathy. Reply","volume":"391","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.slasd.2026.100342_bib0021","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1073\/pnas.082235499","article-title":"One of the two cytoplasmic actin isoforms in Drosophila is essential","volume":"99","author":"Wagner","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.slasd.2026.100342_bib0022","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cm.20475","article-title":"The actin gene family: function follows isoform","volume":"67","author":"Perrin","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.slasd.2026.100342_bib0023","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180143","article-title":"Cardiac and skeletal actin substrates uniquely tune cardiac myosin strain-dependent mechanics","volume":"8","author":"Wang","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/j.slasd.2026.100342_bib0024","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1074\/jbc.RA118.002702","article-title":"High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin-myosin structure and function","volume":"293","author":"Guhathakurta","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0025","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1021\/bi049914e","article-title":"Structural dynamics of actin during active interaction with myosin: different effects of weakly and strongly bound myosin heads","volume":"43","author":"Prochniewicz","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.slasd.2026.100342_bib0026","doi-asserted-by":"crossref","DOI":"10.1063\/1.4900727","article-title":"Fluorescence lifetime plate reader: resolution and precision meet high-throughput","volume":"85","author":"Petersen","year":"2014","journal-title":"Rev Sci Instrum"},{"key":"10.1016\/j.slasd.2026.100342_bib0027","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1087057116680151","article-title":"High-throughput spectral and lifetime-based FRET screening in living cells to identify small-molecule effectors of SERCA","volume":"22","author":"Schaaf","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100342_bib0028","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1087057116674312","article-title":"High-throughput screens to discover small-molecule modulators of ryanodine receptor calcium release channels","volume":"22","author":"Rebbeck","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100342_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105369","article-title":"Drug discovery for heart failure targeting myosin-binding protein C","volume":"299","author":"Bunch","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0030","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/cells9051170","article-title":"Live-cell cardiac-specific high-throughput screening platform for drug-like molecules that enhance Ca(2+) transport","volume":"9","author":"Schaaf","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.slasd.2026.100342_bib0031","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bpj.2011.11.4027","article-title":"Three distinct actin-attached structural states of myosin in muscle fibers","volume":"102","author":"Mello","year":"2012","journal-title":"Biophys J"},{"key":"10.1016\/j.slasd.2026.100342_bib0032","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0005-2728(71)90033-8","article-title":"The purification of cardiac myofibrils with Triton X-100","volume":"245","author":"Solaro","year":"1971","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.slasd.2026.100342_bib0033","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1080\/10408398.2015.1110111","article-title":"Solubilization of myofibrillar proteins in water or low ionic strength media: classical techniques, basic principles, and novel functionalities","volume":"57","author":"Chen","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.slasd.2026.100342_bib0034","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0006-3495(94)80945-2","article-title":"Kinetic mechanism of myofibril ATPase","volume":"66","author":"Ma","year":"1994","journal-title":"Biophys J"},{"key":"10.1016\/j.slasd.2026.100342_bib0035","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1006\/jmcc.1999.1043","article-title":"Effect of ionic strength on length-dependent Ca(2+) activation in skinned cardiac muscle","volume":"31","author":"Smith","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.slasd.2026.100342_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-374841-6.00001-3","article-title":"A practical guide to the preparation of Ca(2+) buffers","volume":"99","author":"Bers","year":"2010","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.slasd.2026.100342_bib0037","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.slasd.2026.100342_bib0038","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1177\/24725552211038379","article-title":"Addressing unusual assay variability with robust statistics","volume":"26","author":"Haelewyn","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100342_bib0039","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ab.2005.08.037","article-title":"Identification of actin as quercetin-binding protein: an approach to identify target molecules for specific ligands","volume":"346","author":"Bohl","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.slasd.2026.100342_bib0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/biof.1314","article-title":"Dietary flavonoid luteolin attenuates uropathogenic Escherichia. Coli invasion of the urinary bladder","volume":"42","author":"Shen","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.slasd.2026.100342_bib0041","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/acs.jnatprod.0c00892","article-title":"Linearolactone and kaempferol disrupt the actin cytoskeleton in Entamoeba histolytica: inhibition of amoebic liver abscess development","volume":"83","author":"Velazquez-Dominguez","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.slasd.2026.100342_bib0042","doi-asserted-by":"crossref","first-page":"14100","DOI":"10.1074\/jbc.RA120.014445","article-title":"Actin-binding compounds, previously discovered by FRET-based high-throughput screening, differentially affect skeletal and cardiac muscle","volume":"295","author":"Guhathakurta","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","article-title":"Targeting the sarcomere in inherited cardiomyopathies","volume":"19","author":"Lehman","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.slasd.2026.100342_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102675","article-title":"Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: toward improved gene therapy for Duchenne muscular dystrophy","volume":"298","author":"Guhathakurta","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102956","article-title":"Early-phase drug discovery of beta-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5","volume":"299","author":"Guhathakurta","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100342_bib0046","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40262-022-01157-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of Rucaparib","volume":"61","author":"Liao","year":"2022","journal-title":"Clin Pharmacokinet"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:05:33Z","timestamp":1794207933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S2472555226000481"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100342","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput discovery of actin-binding compounds for cardiac disorders","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100342"}}